Plasma Technology at MedtecLIVE 2019


At the Nuremberg, Germany's MedtecLIVE, in Regensburg Relyon Plasma GmbH will showcase new motions and developments in the field of atmospheric plasma applications in medical technology.

Direct penetration technology (PDD) is predicted for biomedical and medical applications due to the plasma manufacture of low thermal pressure.

The most recognizable and important features of a plasma for medical technology are defense and disinfection features. Plasma can use cold surface pressure to clean medical equipment and equipment easily, quickly and without using any additional chemicals.

PDD technology makes it possible to make effective inequalities of the methicillin Staphylococcus aureus (MRSA) without the use of antibiotics.

The application of implants in dentistry

Medical engineering materials such as zirconia or titanium pottery and stainless steel, as well as PEEK, Teflon, silicone pollen and potato pots, can be incorporated into wet goods. This building is the basis for a good biocompatibility band and acceptance of the living substances. This technology has already been used for many years to use dentistry in dentistry. Using the surface plasma air pressure plasma will clean the surface, clean the glass and reduce the risk of disease.

Another plasma property is the biological features and smell of smell. To make this particularly possible, Relyon Plasma has developed a special modular model that can be incorporated into a wide range of equipment.

Another way to use plasma technology in the medical field was back treatment of symptoms of skin, skin diseases or diseases. The cold plasma in atmospheric pressure operates in a complicated way: through UV rays, re-active shapes and electricity fields. The interaction of these objects will greatly reduce the growth of bacteria, which accelerates cure.

Viewers are invited to Plasma Relyon's cottage where they are promised to look at plasma technology.

MedtecLIVE will open its doors for the first time in Nuremberg from 21-23 May 2019.

Source link